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Abstract
Introduction: The most common causes of the abrupt onset of unilateral facial weakness are 
stroke and Bell’s palsy. The drug regimen together with electrical stimulation was more effective in 
treating Bell’s palsy than conventional drug treatment alone. We aimed to evaluate more effective 
and safe therapies for the treatment of Bell’s palsy.
Methods: This clinical interventional study was conducted on 30 diabetic patients with Bell’s palsy 
who referred to a pain clinic for 1 year and were treated by low-level laser (LLL). The system of 
House-Brackmann was used for assessing the severity of nerve damage and patients were evaluated 
by electromyography and nerve conduction study (NCS) before and after treatment with low-level 
laser.  These patients had not consumed any other medication for facial nerve palsy. 
Results: In the present study, 30 cases with poorly controlled diabetes mellitus (18 females and 12 
males) were studied. After 12 sessions of low-level laser therapy (LLLT), we could observe complete 
recovery in 18 patients and partial recovery in 6 patients after 3 months. 
Conclusion: The recovery rate showed that LLLT is a safe, reliable and proper alternative approach 
for the treatment of facial nerve palsy, especially in the presence of underlying conditions such as 
diabetes mellitus.
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Introduction
Idiopathic facial palsy is commonly known as Bell’s palsy 
as it was described by Dr. Charles Bell in 1821 as a sudden 
event without a known reason, which influences facial 
never palsy.1  The stroke and Bell’s palsy are the most 
prevalent reasons for the sudden onset of unilateral facial 
weakness. The central or peripheral palsy is defined by 
the patient’s history and neurologic examination. The 
incidence of Bell’s palsy is 10 to 40 cases per 100 000 
people, per year; it is known that it has caused 0.3% of 
all cases of bilateral facial paralysis. Genders are affected 
equally and the median age at the onset is 15-40 years old, 
but it may occur at any age. The left and right sides of 
the face are involved with equal frequency. The abrupt 
onset with facial muscle weakness progressing over hours 
to days could be observed. Its incidence increases in 
cold regions2 Bell’s palsy may be the first manifestation 
of diabetes, and in any patient manifestation with this 
neurological deficit, glucose tolerance should be checked.3 
No persistent association was demonstrated between 
the onset of mononeuropathy and age, gender, diabetic 
treatment and duration, diabetic control, or other diabetic 
complications.4 Thus, the usual site of facial nerve lesion in 
diabetics appears to be distal to the chorda tympani, while 
in patients whose glucose tolerance is normal, no such 
selectivity exists. Some cases of Bell’s palsy may, in fact, be 
a diabetic mononeuropathy.5 Most patients experience a 
full recovery, but some have permanent disfiguring facial 
weakness. However, older age, hypertension, impairment 
of taste, pain except for the ear, and complete facial 
weakness are among poor prognostic factors. In the first 
three days, electrical studies cannot show any alterations 
in affected facial muscles, while a continuous impairment 
of electrical activity is often observed on days 4 to 10. As 
many as 90% of patients have complete recovery when 
excitability returns; in case of lack of excitability, only 
20% of patients have a full recovery. Other reasons for 
the acquired peripheral facial weakness are less likely to 
cause facial weakness. One of the underlying considerable 
diseases is diabetes mellitus.6 The drug combination with 
electrical stimulation was more effective in the rescue 
treatment of Bell’s palsy in relation to conventional drug 
treatment alone. The effectiveness of such sub-threshold, 
continuous, low-frequency electrical stimulation 
suggests a new therapeutic approach to accelerate nerve 
regeneration and improve functional recovery after 
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injury.7 For initiating of the patient’s recovery process, 
the pressure on the nerve may be helpful. The surveys 
supposed that this can be facilitated by steroid or a steroid 
plus an antiviral drug (e.g. acyclovir).8 Short treatment 
duration is considered, but it can cause undesirable 
impacts. It may result in the induction or worsening 
of hyperglycemia, especially in diabetics, although 
patients with diabetes, malignant hypertension, hepatic 
and renal dysfunction may need higher doses.9 Results 
can show combined treatment with low-level laser 
therapy (LLLT) and exercise therapy is correlated with 
a remarkable recovery of facial disability index (FDI) in 
comparison with only exercise therapy. In the treatment 
of neuropathic and neurogenic pains, the proposed 
mechanisms of beneficial effects of lasers include (1) 
increasing the production of ATP in mitochondria and 
increasing cellular oxygen consumption leading to muscle 
relaxation; (2) increasing serotonin and endorphin levels; 
(3) producing anti-inflammatory effects (decreasing 
prostaglandin synthesis); (4) improvement of skin blood 
supply; (5) decreasing the permeability of neuron cell 
membranes to sodium and potassium ions (leading to 
the hyperpolarization of neurons); and (6) increasing 
lymphatic drainage and decreasing edema. It should be 
considered that the intensity and power of the laser have 
various impacts depending on the varying skin color of 
people.10 Accordingly, few studies were conducted about 
the evaluation of the effect of low-level lasers (LLLs) on 
Bell’s palsy treatment; on the other hand, conventional 
treatments have various adverse effects, especially in 
diabetic patients who suffer from diabetes mellitus. We 
decided to determine the effect of LLLs on the treatment 
course of Bell’s palsy.
Materials and Methods 
After being approved by the research and ethical 
committees of Tabriz University of Medical Sciences 
(5/D/973180), this clinical interventional study (identifier: 
IRCT2017011128545N2; https://www.irct.ir/trial/23144) 
was conducted on all patients with Bell’s palsy, who had 
a history of diabetes and referred to pain clinic of Imam 
Reza teaching hospital over one year. The exclusion 
criteria were patients aged under 18 years old, pregnancy, 
having (no) electromyography and nerve conduction 
tests, seizures, cancer, coagulopathies or pacemakers. 
All diabetic patients aged more than 18 years old were 
selected by a consecutive method over one year. Along 
with the recording of demographic data and consumption 
of corticosteroids or other drugs, all patients were visited 
and the severity of facial nerve damage was classified as 
complete, moderate and mild:
1. Total palsy: No identifiable motion on the affected 
side of the face
2. Moderate palsy: Significant motion with asymmetry 
in rest and activity
3. Mild palsy: Symmetric in rest and asymmetric in 
motion 
Then, basic electrodiagnostic tests (including 
electromyography and nerve conduction study [NCS]) 
were performed for all patients, and bilateral compound 
motor action potential (CMAP) was assessed through the 
tests. CMAP is the result of the stimulation of nerve files 
and it monitors muscle response for the evaluation of the 
function of the motor unit. Electromyography (EMG) was 
performed by the Viking Quest device in the physiotherapy 
clinic and the severity of the axonal injury of the facial 
nerve was assessed by the electromyography method and 
compared CMAP amplitude (peak to peak) of two sides. 
For the recording of CMAP, the anterior portion of the 
ear tragus was stimulated for 0.2–0.5millisecond and 
with the frequency of 1 Hz. The potentials were recorded 
of branches of frontalis, orbicularis oris and orbicularis 
oculi nerves on two sides. In this study, the percentage of 
amplitude decline of the CMAP wave of the affected side 
in relation to the healthy side was considered the severity 
index of the axonal injury and classified as follows: 
unimpaired, mildly impaired, moderately impaired, and 
severely impaired.
Then, the rate of muscle activity was assessed by the 
electromyography of muscles (i.e., frontalis, orbicularis 
oris and orbicularis oculi) on 2 sides of the face and 
compared two-sided EMG findings with together. Finally, 
the results were classified as follows: 
1. No voluntary motor unit potential 
2. Single voluntary motor unit potential 
3. Discrete activity pattern 
4. Reduced interference pattern
5. Complete recovery
After electrodiagnosis was conducted, the patients 
underwent 12 sessions of laser therapy by the LLL (3 
times in a week). Laser therapy was provided by the low-
level machine (model BLT-4000; power: 334 mW, dose: 
16 J/cm2, frequency: 100 Hz, area: 1 cm2, accessory: 830 
nm). The diode of the LLL (the wavelength of 980 nm and 
frequency of 100 Hz, energy density of 5 J per every point 
of direct contact with the skin of the face) was taken at 
9 points for a period of one minute. Contact sites in the 
affected side were located near the mastoid process in the 
stylomastoid foramen and two points in every pathway 
of facial nerve branches (these points were selected based 
on previous studies), including the area of the temporal 
branch in forehead, the branch of zygomatic nerve along 
the zygomatic arc, the buccal nerve in the middle portion 
of cheeks over buccal muscles, and the mandibular 
branches in the chin area. 
After 12 sessions of laser therapy, the clinical severity 
of motor palsy of the facial nerve was determined and the 
recovery rate of patients was clinically evaluated: 
1. Complete recovery: the complete return of voluntary 
motion without any asymmetry in rest or activity or 
contraction
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2. Good recovery: incomplete recovery without paresis 
in motion
3. Moderate recovery: incomplete recovery with mild 
paresis in motion
4. Poor recovery: incomplete recovery without paresis 
(i.e., normal motion and contraction).
After the completion of the 1-month treatment, the 
patients were evaluated by electromyography and NCS. 
In addition to the comparison of the recovery rate of 
the patients, their findings were compared with basic 
electromyographic results. After coding, data were 
collected and analyzed by SPSS version 16. The categorical 
and discrete data including gender, consumption of 
corticosteroids or other drugs, the severity of the axonal 
injury of the facial nerve, the pattern of muscle activity 
and the recovery rate or clinical recovery grade were 
assessed and compared by proper method (e.g. chi-square 
by the Monte Carlo’s method, Mann-Whitney U test ). 
The p-value of less than 0.05 was considered statistically 
significant. The cost of basic electrodiagnostic tests was 
provided by the research project. Here we summarized 
House–Brackmann grading in Table 1. 
But we have one question: what are lasers (light 
amplification by stimulated emission of radiation) are 
devices that typically generate electromagnetic radiation 
with a relatively uniform wavelength, phase, and 
polarization, originally described by Theodore Maiman 
in 1960 in the form of a ruby laser. The LLL is a particular 
type of laser which affects biologic systems through non-
thermal means.11 
Results
Our study was conducted on 30 patients with diabetes who 
were selected by the consecutive method. The patients 
did not receive other medications for the treatment of 
palsy, particularly corticosteroids due to their underlying 
disease (based on their endocrinologist’s diagnosis) and 
after confirmation of diagnosis, we treated them by 
12 sessions of LLL. All demographic data are shown in 
Table 2. 
On the basis of the findings, any cases didn’t involve in 
grade II the facial nerve palsy. Three cases (16.7%) were 
affected by grade IV of Bell’s palsy and 12 cases had grade 
V of Bell’s palsy. In addition, fifteen cases had grade VI 
of Bell’s palsy. After 12 sessions of LLLT, we observed 
that these patients had treatment contraindications 
with corticosteroids, while they did not receive any 
other treatment. The House-Brackmann grading scales 
improved to grade I (18 cases), grade II (6 cases), and grade 
IV (6 cases) (Table 3). Then, basic electrodiagnostic tests 
(including electromyography and NCS) were performed 
and the degree of axonal injury in NCS was determined 
based on our mentioned standard scales. The severity 
of axonal injury based on the study of nerve conduction 
amplitude showed that 21 cases had moderately impaired 
amplitude and 9 patients had a severe disorder. Of course, 
the patterns of nerve conduction velocity (NCV) showed 
that 6 patients had a severe impaired function and 18 
cases had a moderate one. Twenty-one cases showed no 
voluntary potential of motor unit, 6 cases had a single 
voluntary motor potential unit, and 3 patients had a 
reduced interference pattern. We followed up all the 
patients by EMG and NCS after 3 months. Finally, we 
observed that 18 (60%) patients experienced recovery. 
There was a statistically significant association between 
laser therapy and the pattern of recovery in EMG (P value 
<0.001). Here, we summarized the distribution of EMG 
patterns before and after the treatment by the LLL in 
Table 4.
Here, we evaluated the patterns of NCV after one 
month and 3 months of treatment by laser. There was 
no significant association between the recovery pattern 
and laser therapy (P = 0.754). However, after 3 months, 
we could observe a significant association between the 
recovery pattern and laser therapy (P < 0.001). In the 
present study, the results showed that females experienced 
Table 1. House-Brackmann Grading
Grading Function Gross At Rest Motion
Grade I Normal Normal Normal Normal
Grade II Slight dysfunction
Slight noticeable weakness on close 
inspection; may have very slight 
synkinesis
Normal symmetry and tone
Forehead - moderate to good function; 
eye - complete closure with minimum 




Obvious but not disfiguring difference 
between two sides; noticeable but not 
severe synkinesis, contracture, and/or 
hemifacial spasm
Normal symmetry and tone, Motion: 
forehead - slight to moderate 
movement; eye - complete closure 
with effort; mouth - slightly weak with 
maximum effort.
Grade IV
Moderate to  severe 
dysfunction
Obvious weakness and/or disfiguring 
asymmetry
Normal symmetry and tone
Forehead - none; eye - incomplete 
closure; mouth - asymmetric with 
maximum effort.
Grade V Severe dysfunction Only rare perceptible motion Asymmetry
Forehead - none; eye - incomplete 
closure; mouth – slight  movement.
Grade VI
Total paresis, no 
movement
- - -
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a higher grade of recovery but 6 males had a complete 
recovery. These results were confirmed by EMG and NCV 
studies after completing 12 sessions of treatment.
Discussion
The results of the present study showed that diabetic 
patients had a higher grade of Bell’s palsy, which was 
confirmed by EMG and NCV results. After LLLT, we 
observed that 6 cases had a complete recovery and 4 
patients experienced mild sequelae after the treatment such 
as mild facial asymmetry and mild drooping of the brow. 
In the follow-up period after 3 months, we could not find 
any symptoms of recurrence and 6 cases of patients who 
had an incomplete recovery reached a complete recovery 
based on objective, EMG and NCV monitoring. According 
to clinical training and new literature, management of 
Bell’s palsy is evolving.12 Zhao et al stated that the peak 
age of Bell’s palsy is in the fourth decade of life, 55.1% 
being men. These results are similar to our demographic 
values and gender distribution. The highest prevalence of 
Bell’s palsy is seen during spring and summer. Zohrevandi 
et al showed that men and women are equally affected 
with similar occupational distribution with the peak age 
Table 2. The Demographic Data
Variables Age (Mean ±SD) Weight (kg) Height (cm)
Female (n=18) 40.66±11.74 55.5±6.28 163. 83±9.49
Male (n=12) 42.25±13.67 74±69.5 179±8.28
Table 3. House-Brackmann Grading Scale Before and After the Treatment by the Low-Level Laser on Third Month
House-Brackmann Scaling Grades
Grade I Grade II Grade III Grade IV Grade V Grade VI
Pre
Female 0 (0.0) 0 (0.0) 0 (0.0) 3 (16.7) 6 (33.3) 9 (50) 
Male 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 6 (50) 6 (50) 
Post (3 months)
Female 12 (66.7) 6 (33.3) 0 (0.0) 0 (0) 0 (0) 0 (0.0) 
Male 6 (50) 0 (0.0) 0 (0.0) 6 (50) 0 (0) 0 (0.0) 
Data are shown as No. (%).
Table 4. The Finding of NCV Study Before and After the Treatment by the Low-Level Laser in the First and Third Months
Pre Post (1 month) P Value Post (3 months) P Value
NCV study




Moderately impaired 21 (70) 18 (60) 6 (2.0)
Mildly impaired 0 (0.0) 6 (20) 6 (20)
Unimpaired 0 (0.0) 0 (0.0) 18 (70)
EMG study




Single voluntary motor unit potential 9 (30) 6 (20) 0 (0.0)
Discrete activity pattern 0 (0.0) 6 (20.0) 6 (20.0)
Reduced interference pattern 0 (0) 6 (20) 6 (20)
Complete recovery 0 (0.0) 0 (0.0) 18 (60)
Data are shown as No. (%).
of the fourth decade of life and it occurs more in summer 
and autumn. The most common comorbid disease is 
diabetes mellitus.13 The high grade of nerve damage (V 
and VI) is observed in diabetic patients.14 Pourmomeny 
et al stated that the incidence of Bell’s palsy is 23 to 35 in 
100 000 cases. The reason for facial nerve palsy in half of 
the cases is idiopathic and incomplete recovery correlates 
with facial muscle weakness, contracture, hyperkinesis, 
atrophy, and synkinesis.15 Electrophysical assessment is 
commonly performed for the prediction of prognosis 
and NCS can evaluate the severity of facial nerve about 
48 hours after the onset of symptoms.16 Diabetes mellitus 
(DM) has been reported to be unrelated to the prognosis 
of Bell’s palsy, whereas the studies by Kang et al have 
found that DM worsens prognosis. Various types of 
therapeutic approaches are available, but the effectiveness 
of definitive treatments are unknown.17 The traditional 
systemic corticosteroid therapy in acute peripheral Bell’s 
palsy in patients with DM type 2 can cause hyperglycemia, 
and local therapy is required as an alternative treatment 
approach.18,19 Palsy could be treated by corticosteroids up 
to the rate of 17% in a complete recovery by treatment 
difference.20 
 The LLL can relieve pain, inflammation, and edema and 
help in healing wounds and preventing tissue injury; these 
effects were accepted many years before the invention 
of lasers. Lasers (light amplification by stimulated 
emission of radiation) are devices that typically generate 
electromagnetic radiation with a relatively uniform 
wavelength, phase, and polarization, originally described 
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by Theodore Maiman in 1960 in the form of a ruby laser. 
The LLL is a particular type of laser which affects biologic 
systems through non-thermal means. Leal-Junior et al in 
1967 reported non-thermal effects of lasers on mouse hair 
growth. According to Leal-Junior et al, the characteristic 
of LLLs are as follows: power output of lasers = 0.001-
0.1 W and in the range = 300-10 600 nm; and pulse rate 
beginning from 0.11 Bernal et al presented their 6-year 
practice in treatment by a laser for the rehabilitation of 
Bell’s palsy, but they used a 904 nm diode GaAs and 632.8 
(HeNe) laser. Laser Irradiation was conducted on the 
region of the facial nerve in 8 points for 5 minutes and 4 
sessions over 1 week. The patients who received treatment 
within 2 weeks were recovered 100% and this recovery 
was obtained without additional medication. They 
concluded that LLLT is a safe, noninvasive, easy-to-apply 
and comparatively side-effect-free modality offering a 
complementary and effective tool in the treatment of 
facial paralysis.21 Another study was on the systematic 
evaluation of the LLLT effect on the regeneration of nerves 
in children with facial nerve palsy. A total of 31 patients 
were divided into 2 groups. Group 1 received LLLT and 
group 2 was treated with the conventional method. Two 
diode lasers were used (i.e., 670 and 830 nm wavelengths 
& 100 mW respectively 300 mW max of output power). 
The results indicated the validity of this method in that 
87.5% of the patients treated with the laser compared to 
only 60.0% of the patients in the control group displayed 
a complete recovery.22 Another survey evaluated the effect 
of LLLT plus exercise treatment on functional outcome 
during recovery time in facial palsy. In this study, 46% 
(mean age 41 ± 9.7 years; 40 women and 6 men) were 
divided into 2 groups. One group received laser treatment 
at a wavelength of 830 nm, power output of 100 mW, and 
a frequency of 1 kHz using a gallium-aluminum-arsenide 
(GaAIAs, infrared laser) diode laser. Laser treatment 
(mean energy density of 10 J/cm2) was administered 
to 8 points on the affected side of the face 3 times per 
week, for a total of 6 weeks. In the laser group, significant 
improvement in FDI scores was observed relative to the 
baseline in weeks 3 and 6 (P < 0.001). Good FDI scores 
were remarkably higher in weeks 3 and 6 in the laser 
group than the exercise group (P < 0.05).23 In 1 case report, 
the House-Brackmann grading system was applied for 
the assessment of facial nerve recovery. A 3-year-old boy 
with facial nerve palsy experienced full recovery after 11 
sessions of LLLT after a total of 3 weeks. The 660-nm laser 
with low (10 J/cm2) or moderate (60 J/cm2) energy density 
can help to accelerate the neural recovery. For these 
reasons, from the sixth session onward, the energy density 
progressively decreased based on the patient’s report as 
well as clinical observations. The output power of 60, 50, 
and 40 mW was administered for sessions 6, 7, and 8.24 The 
some evidence for LLLT efficacy in individuals with Bell’s 
palsy were obtained by volunteers who participated in 
an randomized controlled trial. Associated outcomes are 
alterations in disease status, functional outcomes, quality 
of life, and treatment-related morbidity. Bell’s palsy may 
be completely treated over several months, so it is difficult 
to determine improvements from laser therapy over the 
natural resolution of disease. The available randomized 
controlled trial did not include a sham treatment; LLLT 
was associated with better results in this study. In another 
study, patients were treated with physiotherapy. They 
suggested a statistical improvement after 6 weeks of the 
treatment based on the House-Brackmann scale and 
FDI scores, with the highest cure rate after this period.25 
The prognosis of Bell’s palsy is correlated with the onset 
of recovery. Early recovery is associated with a desirable 
prognosis. Recovery within 1 week, 1 to 2 weeks and 2 to 
3 weeks are an indication of 88%, 83%, and 61% complete 
recovery respectively. Other factors that show a poor 
prognosis are as follows: hypertension and DM.26 Sham-
controlled surveys and additional studies are required 
for the comparison of LLLT with other alternative palsy 
treatments. The evidence is insufficient to determine 
the effects of technology on the health outcome.16 In the 
present study, we could show a rate of 70% recovery after 
12 weeks of LLLT.
Conclusion
We applied LLLT for the treatment of 30 patients with Bell’s 
palsy. LLLT was effective in these cases. The recovery rate 
showed that LLLT is a safe, reliable and proper alternative 
approach to the treatment of facial nerve palsy, especially 
in conditions such as diabetes where we cannot use 
conventional medications such as corticosteroids due to 
their complications (e.g. hyperglycemia).
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